Tal1/SCL is a basic helix-loop-helix transcription factor critical for normal hematopoiesis. To understand the mechanisms underlying transcriptional regulation by Tal1/SCL, we combined an in vitro DNA binding strategy and an in vivo chromatin immunoprecipitation (ChIP) analysis to search for Tal1/SCL target regions in K562 erythroleukemia cells. A 0.4 kb genomic DNA clone containing two Tal1/SCL binding E-boxes and a GATA and a SATB1 binding motifs (EEGS) was identified that localized to the pericentromeric region with high homology to satellite 2 DNA. Pericentric DNA is related to heterochromatin and gene inactivation. We found that Tal1/SCL could complex with the histone H3 lysine 9 (H3K9)-specific methyltransferase Suv39H1.
Tal1/SCL is a basic helix-loop-helix transcription factor critical for normal hematopoiesis. To understand the mechanisms underlying transcriptional regulation by Tal1/SCL, we combined an in vitro DNA binding strategy and an in vivo chromatin immunoprecipitation (ChIP) analysis to search for Tal1/SCL target regions in K562 erythroleukemia cells. A 0.4 kb genomic DNA clone containing two Tal1/SCL binding E-boxes and a GATA and a SATB1 binding motifs (EEGS) was identified that localized to the pericentromeric region with high homology to satellite 2 DNA. Pericentric DNA is related to heterochromatin and gene inactivation. We found that Tal1/SCL could complex with the histone H3 lysine 9 (H3K9)-specific methyltransferase Suv39H1.
Binding of Tal1/SCL to EEGS chromatin correlated with hypermethylation of H3K9 and the association of heterochromatin protein HP1 to this region. In Rep4 reporter gene assays, EEGS affected repression in a manner dependent on the expression level of Tal1/SCL that was accompanied by increased H3K9 methylation in chromatin associated with EEGS and a linked promoter. A specific histone deacetylase inhibitor, trichostatin A (TSA), relieved Tal1/SCL-mediated repression by EEGS. In addition, SATB1 bound EEGS chromatin and promoted Tal1/SCL EEGS-dependent repression. We expand the list of potential interacting partners for Tal1/SCL by demonstrating direct associations of Tal1/SCL with SATB1 and with Suv39H1. These results reveal a novel mechanism of action for Tal1/SCL and implicate heterochromatin-like silencing via a cis-acting binding motif for transcriptional repression.
Modification of the amino termini in core histones by acetylation, phosphorylation or methylation effects chromatin-based modulation of gene expression and contributes to epigenetic control of gene regulation (1, 2) . Gene inactivation is associated with the lowest level of histone acetylation, condensed chromatin regions, and methylation of histone H3 at lysine 9 (H3-MeK9), while gene activation is associated with a marked increase in histone acetylation. The highest levels of acetylation are observed at regulatory regions upstream of genes, as exemplified by the 5'hypersensitive region of the chicken β-globin locus where high histone acetylation protects downstream promoter DNA from methylation (3, 4) . Tissue specific transcription factors, including NF-E2 and GATA-1, promote transcription of the β-globin genes by inducing both histone acetylation and methylation of histone H3 lysine 4 (H3-MeK4) (3, 5) . SATB1 can recruit histone remodeling enzymes to activate or repress gene expression (6, 7) and has been implicated in regulation of globin gene expression (8, 9) . Methylation of histone H3 at lysine 9 (H3-MeK9) by site-specific histone methyltransferases, such as Suv39H1, generates a binding site for heterochromatin protein 1 (HP1). This contributes to propagation of heterochromatic subdomains (10) and illustrates the link between H3-MeK9, gene silencing and heterochromatin formation. The Suv39h-HP1 histone methylation system is required for DNA methylation at pericentric heterochromatin (11) where histone deacetylation and methlylation participate in chromosome segregation mediated by mSds3, a protein associated with the mSin3/HDAC (histone deacetylase) corepressor complex (12) . Transcriptional repression can be mediated by mSin3A interaction with sequence-specific transcription factors such as Tal1/SCL, and Tal1/SCL-mSin3A repression can be relieved by the specific histone deacetylase inhibitor, trichostatin A (TSA) (13) .
Tal1/SCL, a basic-helix-loop-helix (bHLH) transcription factor, is indispensable for embryonic survival and hematopoietic stem cell formation during development (14, 15) . In adult mice, Tal1/SCL is not required for hematopoietic stem cell reconstitution of bone marrow but is required for differentiation along the erythroid lineage (16) Tal1/SCL forms heterodimers with other bHLH proteins, including E2A and E47, and recognizes E-box motifs (CANNTG) in DNA with a preferred binding sequence of 5´-AACAGATGGT-3´ (17) . These Tal1/SCL heterodimers can regulate transcription positively or negatively by association with transcriptional co-activators or co-repressors (13, 18) . Cooperation of Tal1/SCL with partners LMO2, GATA-1, E47, and coactivator CBP/p300 positively regulates select erythroid gene expression and erythropoiesis (18) (19) (20) . Such a Tal1/SCL multi-protein complex with Ldb1 activates protein 4.2 through two E-box GATA elements (20) and with Sp1 regulates Glycophorin A (21) . A Tal1/SCL multifactorial complex enhances the c-kit promoter in B-cells but does not require Tal1/SCL or GATA binding motifs (22) . The DNA binding domain is dispensable for Tal1/SCL rescue of hematopoietic stem cell formation (23) , and for erythroid differentiation of human CD34 + cells, although some differences are observed in CD34 function and glycophorin A expression (24) . In early erythroid cells, histone acetylation of the α-globin gene is initiated at the far upstream region and is associated with binding by a complex containing GATA-2 (prior to the induction of GATA-1), NF-E2 and Tal1/SCL (25) . One proposed role for Tal1/SCL in the β-globin locus is the enhancer activity of hypersensitivity site 2 in the locus control region (LCR) (26) that is required for high level transcription of the β-like globin genes (27) . Tal1/SCL interacts with the nuclear co-repressor mSin3A, a subunit of the NURD (nucleosome remodeling and histone deacetylase) complex, and the histone deacetylase HDAC1 to repress transcription (13) . This suggests that alteration in chromatin structure may underlie Tal1/SCL-mediated transcriptional repression. Hence, Tal1/SCL associates with ubiquitous and tissue-specific transcription factors to regulate gene expression and can function as a transcription activator or repressor depending on its interacting partners.
Although the Tal1/SCL preferred DNA binding sequence is known, only a small number of Tal1/SCL target genes have been identified (20) (21) (22) 28) . Therefore, delineation of the genomic regions to which Tal1/SCL is recruited should provide insight into the mechanisms of Tal1/SCLdirected gene expression during hematopoiesis. In searching for additional Tal1/SCL genomic binding sites, we isolated an in vivo Tal1/SCL target sequence from K562 erythroid cells. This sequence, EEGS, localizes to chromosomes 1 and others at the pericentromere, a region associated with formation of heterochromatin and gene silencing. We established that the EEGS element is a target of Tal1-mediated repression through a chromatin remodeling mechanism involving H3K9 methylation and HP1 binding. Our study expands the interacting partners for Tal1/SCL and suggests a novel mechanism by which Tal1/SCL can repress transcription.
Materials and Methods
Cell culture and nuclear extracts -Erythroleukemia K562 cells and HeLa cells were cultured in RPMI 1640 medium (Invitrogen Corporation, Carlsbad, CA) and supplemented with 10% fetal bovine serum (FBS), penicillin and streptomycin (100 µl/ml) at 37°C with 5% CO 2 . For RT-PCR expression analysis, the total RNA was prepared from washed cells and first-strand cDNA was synthesized using Moloney murine leukemia virus (MuLV) reverse transcriptase and oligo(dT) 16 (PE Applied Biosystems, Foster City, CA). PCR analysis was carried out using genespecific primers. Nuclear extracts were prepared from K562 cells as previously described (29) . K562 cells were centrifuged at 1000 rpm for 5 min, washed with cold PBS, resuspended in buffer containing 10 mM Hepes, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.5 mM PMSF, and incubated on ice for 5 min. Cells were centrifuged at 2000 rpm for 2 min and washed with 1 ml of the same buffer. The cell pellet was resuspended in 2 X volumes of 20 mM Hepes, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, and 0.5 mM PMSF, and were incubated on ice for 30 min. The cell suspension was centrifuged at 10,000 rpm for 10 min at 4˚C and the supernatant collected. Isolation of Tal1/SCL-bound DNA fragments in vitro -Genomic DNA target sites for Tal1/SCL were isolated by incubating genomic DNA with K562 nuclear extract followed by isolation of DNA-Tal1/SCL complexes using a Tal1/SCLspecific antibody (Geneka Biotechnology, Inc. Quebec, Canada) (30) . In brief, K562 genomic DNA was sonicated to an average size of 0.6 kb, ligated to a common linker DNA fragment (Sense: 5´-GCGGTGACCCGGGAGATCTGAATTC-3´; Antisense:
5´-GAATTCAGATC-3´), and incubated with K562 nuclear extract. DNA-protein complexes were immunoprecipitated with anti-Tal1/SCL antibody and isolated using Protein Gagarose in 1 ml binding buffer and overnight rotation at 4˚C. The reaction mixture was centrifuged for 10 sec, washed rapidly several times with binding buffer (20 mM Tris HCl pH 8.0, 0.5 mM EDTA, 5 mM MgCl 2 ) and digested with proteinase K. DNA was purified by phenolchloroform extraction and ethanol precipitated. The DNA was then amplified by ligation-mediated PCR (LM-PCR) using the oligonucleotides previously described as primers. The selection procedure of binding, immunoprecipitation, and LM-PCR was repeated using 100 ng of amplified DNA, and after three cycles of selection, a library was constructed by ligation of the PCR product into the pCR 4-TOPO vector (Invitrogen, Carlsbad, CA). DNA binding assays -For electromobility shift assays (EMSA), DNA probes were labeled with γ-32 P-ATP using T4 polynucleotide kinase (New England BioLabs Inc. Beverly, MA). Binding of nuclear extract to DNA probes was carried out in a 24 µl reaction volume containing 20 mM Tris HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 5% NP-40 and 0.1mg/µl NP-40, 0.1 mg/µl bovine serum albumin and 10 mM dithiothreitol. The reaction mix was incubated for 30 min at 4-10˚C. DNAprotein complexes were analyzed by electrophoresis in a 4% non-denaturing polyacrylamide gel, followed by autoradiography. Slide preparation -Metaphase chromosome spreads were prepared from the peripheral blood leukocytes of a male donor. Whole blood cells were grown for 72-96 hr in RPMI medium (Invitrogen, Carlsbad, CA) supplemented with 15% fetal bovine serum, penicillin-streptomycin (100 u/ml) and phytohemagglutinin (5 µg/ml) (Murex Diagnostic Ltd. Dartford, England). Cells were treated with ethidium bromide (5 mg/ml) for 1.5 hr, the reaction was stopped with colcemid (0.05 mg/ml) treatment for 15 min during the logphase growth followed by treatment in hypotonic KCl (0.54%) for 15 min at 37˚C, the cells were harvested, and fixed in cold (-20˚C) methanolacetic acid (3:1). Fresh slides were equilibrated in 2× SSC solution at 37˚C and dehydrated in increasing ethanol solutions of 70%, 80%, and 95%. Fluorescence in situ hybridization -Fluorescence in situ hybridization (FISH) was performed as previously described (31, 32) . In brief, the DNA probe from the BAC clone (a 129 Kb human genomic fragment containing the entire EEGS sequence) (Research Genetics, Huntsville, AL) was labeled with Digoxigenin-11-dUTP (Vysis, Downers, Grove, IL) by nick-translation (Boehringer Mannheim, Indianapolis, IN) and ethanol precipitated in the presence of 50× herring sperm DNA and 50× Cot-1 human DNA. The DNA pellet was resuspended in Hybrisol solution (50% deionized formamide/10% dextran sulphate/2× SSC) to a final concentration of 25 ng/ml. Slides were denatured in 70% formamide/2× SSC at 72˚C for 2 min, dehydrated sequentially in cold (-20˚C) ethanol solutions of 70%, 85%, and 100% for 2 min and air-dried. Probes were denatured at 78˚C for 10 min and then incubated for 30 min at 37˚C for preannealing. A total of 250 µg of DNA probe was applied to the slide. Overnight hybridization was done in a humidified chamber at 37˚C. Posthybridization washes were at 45˚C in 50% formamide/2× SSC (5 min × 3), 1× SSC (5 min × 2) and 0.1× SSC (5 min × 2). Detection was performed using Rhodamine-conjugated antidigoxigeninRhodamine (40 min at 37˚C) followed by washing in 4× SSC/0.1% Tween 20 solution at room temperature for 2 min followed by counterstaining with DAPI-antifade (0.25 mg/ml). Digital image analysis -Digital acquisition of gray scale images was done using a charge-coupled device Photometrics CCD camera SenSys (Photometrics, LTD, Tucson, AZ) interfaced to a Power PC 1800 computer and mounted on a Zeiss Axiophot-2 epifluorescence microscope. Images were acquired using filters specific for DAPI, fluorescein and rhodamine (TR1, TR2, and TR3; Chroma Technologies, Brattleboro, VT) and IP Lab Image software (Scanalytics Inc., Fairfax, VA) (31) . Chromatin immunoprecipitation -Chromatin immunoprecipitation (ChIP) was carried out as previously described (33) . Formaldehyde was added to the cell cultures at a concentration of 1% (v/v) of the culture medium. Fixation proceeded at 22˚C for 10 min and was stopped by the addition of 125 mM glycine. Cells were washed twice with PBS, resuspended in binding buffer containing 0.1% SDS, 0.1% sodium deoxycholate, 1% Triton X-100 and 140 mM NaCl (RIPA buffer) and incubated at room temperature for 10 min. The lysed cells were sonicated for 4 min at a power setting level of 4 with the Ultrasonic Processor (HEAT system, Farmingdale, NY). Cell debris was removed by brief centrifugation (4000 rpm for 1 min). 300 µl of the chromatin suspension and 20 µl of protein A-Sepharose beads were used for immunoprecipitation with anti-Tal1/SCL antibody, anti-SATB1 serum or preimmune serum. The immunoprecipitates (IP fraction) were washed three times with RIPA buffer. After reversal of crosslinking at 65˚C for 8 hr, DNA was purified by proteinase K digestion, phenol-chloroform extraction and ethanol precipitation. The PCR primers for the EEGS element are as follows: Forward:
5´-TCAATAATGATCCCTTTCGAGTCC-3´; Reverse: 5´-TGGAAACACCATCGAATTGAAAC-3´. After PCR analysis, the reaction products were confirmed by DNA sequencing. Construction of Reporter gene plasmid -Pairs of complementary oligonucleotides (104 bp) were synthesized based on the native or mutated EEGS sequence (Table 4) containing the core-binding domain. To create the luciferase reporter plasmid pEEGS, the EEGS oligonucleotides were annealed and inserted into the BglII and KpnI sites of the pGL2-promoter vector containing the SV40 promoter and the luciferase reporter gene (Promega, Madison, WI). To create the pREP4/Luc-EEGS reporter vector, the EEGS-SV40 promoter fragment was excised from pEEGS and inserted between the KpnI and Hind III sites of pREP4/Luc. For each transfection, 1.0 X 10 7 K562 or HeLa cells were transfected with a total of 5 µg plasmid DNA using the Superfect reagent (Qiagen, Valencia, CA). After 48 hr, cells were harvested and lysed in 300 µl of reporter lysis buffer (Promega, Madison WI) and luciferase activity was assayed using a Monolight 2010 luminometer (Analytical Luminescence Laboratory, San Diego, CA). The RSV-β-Galactosidase vector (Promega, Madison, WI) (0.1 µg) was co-transfected as an internal control for normalizing transfection efficiency. For cotransfection, 2.5 µg of the reporter gene construct was cotransfected with the Tal1/SCL expression vector (hTal1/SCL-pcDNA1.1), SATB1 expression vector (pECE-AT 1146) (34) or vector without insert to make up the 5 µg total of plasmid DNA. Means and standard deviations were determined from independent transfection assays (n=3). Co-immunoprecipitation -For coimmunoprecipitation, 100 µg of cell nuclear extract was incubated with antibody to Tal1/SCL (from E. Bresnick), SUV39H1 or SATB1, or preimmune serum (as negative control), and protein A-agarose (Santa Cruz Biotechnology, Inc. Santa Cruz, California) in 1 ml of binding buffer (0.5% NP-40, 10 mM Tris-HCL, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 10 µg/ml Leupeptin, 10 µg/ml Aprotinin) for 3 hr at 5˚C. The reaction mixture was pelleted by brief centrifugation. The pellet was resuspended in 1 ml of binding buffer, rotated at 5˚C for 5 min and briefly centrifuged. The washing process was repeated three times. The immunoprecipitated complexes were separated on a polycrylamide gel. Antibody to Tal1/SCL (Geneka Biotechnology, Inc. Quebec, Canada), SUV39H1 or SATB1 was used for Western blot analysis of bound proteins.
Real-time quantitative PCR analysis -Real-time
quantitative analysis was carried out as previously described (35) . In brief, PCR analyses were used to determine the amount of selected ChIP DNA using DNA specific primers and fluorescent labeled TaqMan probes (6- (36) . Primers and probe for EEGS were synthesized (Forward: 5´-CAATAATGATCCCTTTCGAG-3´; Reverse: 5´-GCTAAAGGAATCAACATCG-3´; Probe: 5´-CGTTTCAATTCGATGGTGTTTC-3´).
RESULTS

Isolation of new genomic Tal1/SCL binding sites -
Earlier searches for Tal1/SCL binding sequences identified Tal1/SCL specific DNA motifs, but were less successful in identifying target genes (28, 37) . In chromatin immunoprecipitation (ChIP) assays, 10% of the Tal1/SCL binding motifs from murine erythroleukemia MEL cells appeared in tandem with a GATA site, including one that exhibited positive transcriptional activity and localized to the intron of a gene of unknown function that was homologous to the corresponding sequence for the N-terminus of otegelin (28) . To expand on target genes of Tal1/SCL, we combined an in vitro DNA binding strategy with ChIP. This method was previously used to identify a class of chromatin boundary elements (30) . The preliminary in vitro screen offers the ability to perform several cycles of selection with the possibility of enriching for Tal1/SCL specific target DNA sequences that are then confirmed by ChIP analysis. Total K562 genomic DNA was fragmented, ligated to a common linker DNA, and incubated with K562 nuclear extract. Complexes containing Tal1/SCL binding to DNA were selected by immunoprecipitation using Tal1/SCL specific antibody. Purified DNA was PCR amplified and the selection process was repeated to increase specificity for enrichment of DNA fragments binding to Tal1/SCL. The sequences were confirmed by electrophoretic mobility shift assay (EMSA) incorporating the preferred Tal1/SCL binding sequence into the probe T1 (5´-ACC TGA A CAGATG GT CGG CT-3´) ( Figure 1A lanes 1  to 10) . DNA was subjected to three cycles of selection, and DNA fragments exhibiting Tal1/SCL binding were used for library construction. Individual clones demonstrating competition for Tal1/SCL binding were sequenced and compared with previously sequenced genomic DNA using the NCBI (National Center for Biotechnology Information) advanced BLAST search (38) . Among the 75 sequenced DNA clones that varied in length from 300 to 500 bp, no known genes were identified. About 60% of the fragments share homology to the genomic DNA working draft sequences from different chromosomes. One clone, EEGS, of 388 bp had the highest homology score from the BLAST search and exhibits full-length homology with genomic DNA. EEGS was able to compete for Tal1/SCL binding at a level comparable to the preferred Tal1/SCL binding sequence ( Figure 1A lanes 11 to14). The specific binding of EEGS to Tal1 was further confirmed by the titration of EEGS as competitor in EMSA ( Figure 1B) . The EEGS sequence localized in satellite DNA -EEGS contains two E-box motifs, including the preferred Tal1/SCL binding motif CAGATG (17), a GATA binding site and an overlapping SATB1 binding sequence consisting of multiple short ATC sequences of 15 to 19 bp ( Figure 1C ). SATB1 binds a double-stranded base-unpairing region and specifically recognizes a specialized DNA context (an ATC sequence context rather than simply "ATC-rich") characterized by a cluster of sequence stretches with well mixed As and Ts but either Cs or Gs exclusively on one strand (39 Figure  2A ). Chromatin prepared from K562 erythroleukemia cells was immunoprecipitated with anti-Tal1/SCL antibody. DNA was isolated and analyzed by PCR using primers specific for EEGS ( figure 1C ). Tal1/SCL-selected chromatin DNA gave rise to an EEGS-specific product (Figure 2A, lanes 3 to 5) . In contrast, no product was observed using primers specific for β-actin (Figure 2A, lanes 11 to 13) . Furthermore, DNA from chromatin selection using preimmune serum did not produce any EEGS specific product (Figure 2A, lane 8) . These data show that EEGS can bind Tal1/SCL in vivo (Figure 2A ) as well as in vitro ( Figure 1A and Figure 1B ). To determine if the two E-box motifs in EEGS could bind directly to Tal1/SCL, probes were designed for EMSA that were specific for Ebox1 or E-box2 (Figure 2 , B and C). We found that Tal1/SCL in K562 nuclear extract bound to the E-box1 probe (5´-GATTCCATTTGATTCCATTC-3´) ( Figure 2C Figure 2C, lane 6) , but not by a competitor in which E-box2 was mutated to CATCCG ( Figure 2C, lane 7) . Addition of antiTal1/SCL antibody introduced a high molecular weight supershift band ( Figure 2C, lane 9) . These data show that both E-box1 and E-box2 are capable of binding to Tal1/SCL. Tal1/SCL is known to interact with GATA-1 through the transcription factor LMO2 that acts as a bridging molecule between Tal1/SCL and GATA-1 (19) . To assess the binding capacity of the GATA-motif in EEGS, several probes were constructed ( Figure 2D ). Probe E2G spanned the E-box2 (CATCTG) and GATA (TGATAC) motifs (5´-CATTTCCATCTGATGATGATTCCATTCGAT TCCATTCAATGATACC-3´). This probe resulted in an additional band migrating faster than the Tal1/SCL band ( Figure 2D , lane 2) compared with probe E2 (Figure 2D, lane 1) , and both bands were competed with cold probe ( Figure 2D, lane 4) . Only the faster migrating band was competed with a GATA-1-specific DNA competitor ( Figure 2D , Lane 3), suggesting that this faster migrating band represented binding by a GATA-binding protein.
The faster migrating band was also absent in assays using probe E2mutG with the GATA motif mutated to TCTATC ( Figure 2D, lane 6) . We could not distinguish between GATA-1 and GATA-2 binding as both proteins yielded similarly shifted bands and bound to the GATAspecific DNA competitor. Addition of anti-GATA-1 ( Figure 2D, lane 10) or anti-GATA-2 ( Figure  2D, lane 11) antibodies diminished the intensity of this band. The absence of a band shift with the GATA antibodies is likely due to the fact that these antibodies were raised against the peptide involved in DNA binding.
In addition to the E-box, EEGS contains an ATC-rich SATB1 binding sequence. Using this SATB1 binding site as a probe (EEGS-S: 5'ATT CGA TTC CAT TCT ATG ACG ATT CCA TTC ATT TCC ATC TGA TGA TGA TTC CAT TCG ATT CCA TTC AAT GAT 3') in EMSA, we showed that EEGS binds SATB1 in vitro ( Figure  2E ). The binding of SATB1 to EEGS was competed by the SATB1 binding site taken from the immunoglobulin heavy-chain enhancer (Wt (25) 7 ) (5´-(TCTTTAATTTCTAATATATTTAGAA) 7 -3´) ( Figure 2E, lane 3) and also by cold probe ( Figure  2E , Lane 4). A mutated core sequence (mut (24) 8 (5'-(TCTTTAATTTCTACTGCTTTAGAA) 8 -3') (39) did not compete for the binding by SATB1 ( Figure 2E, lane 5) . Specific binding by SATB1 was confirmed using a rabbit anti-SATB1 serum that markedly reduced the intensity of the SATB1-probe complex ( Figure 2E, lane 6) . Binding of SATB1 to EEGS in vivo was also demonstrated by ChIP analysis of K562 cells using a SATB1 antibody ( Figure 2F) . A PCR product using EEGS specific primers was produced using DNA from anti-SATB1 selected chromatin ( Figure 2F , lanes 6 to 9) comparable to that from anti-Tal1/SCL selected chromatin ( Figure 2F, lane 3) , while no PCR product was observed in DNA selected using preimmune serum (α) ( Figure 2F, lane 4) . EEGS mediates negative transcriptional activityTal1/SCL binding to the EEGS sequence, which was localized to the chromosome 1 pericentromere, raises the possibility that EEGS might be involved in pericentromere mediated heterochromatin formation and transcriptional repression. An updated BLAST search showed EEGS localization to pericentromeric regions in chromosomes 1q11, 1q12, 10q11 and 22q11. A BLAT search showed that EEGS also localized to the pericentromere of chromosome 2 (2p11.1).
Pericentromeric heterochromatin can be transcriptionally active and give rise to transcripts spanning the major satellite repeats (11) . EEGS sequence homology searches identified corresponding transcripts in a differential library constructed from human primary erythroid progenitor cells (40) . To determine the effect of EEGS on transcription activity, a luciferase reporter gene was constructed containing the EEGS core sequence upstream of the SV40 promoter (EEGS-SV) ( Figure 3A) . These constructs were transfected into K562 cells and reporter gene activity determined. The EEGS core sequence reduced promoter activity by 2.7 fold. Repression by EEGS was further enhanced by cotransfection with expression vectors for Tal1/SCL or SATB1 ( Figure 3B ). Repression by EEGS was diminished with mutation of E-box1 or E-box2. Mutation of both E-boxes in the same construct eliminated repression and restored transcriptional activity close to that for the SV40 control vector without EEGS. Cotransfection with the expression vector for Tal1/SCL had little effect on transcriptional activity of the mutant EEGS when both E-boxes were mutated. Repression by EEGS was reduced but detectable following mutation of the GATA-binding site and decreased even further when combined with mutation of Ebox1 or E-box2. In HeLa cells that do not express Tal1/SCL or SATB1, EEGS did not repress transcription, and activity of the EEGS-SV construct was comparable to the SV40 control construct ( Figure 3C ). Interestingly, cotransfection of EEGS-SV with the Tal1/SCL expression vector in HeLa cells decreased EEGS-SV reporter gene activity by three-fold. Cotransfection of EEGS-SV with the SATB1 expression vector also decreased reporter gene activity, but was to a lesser extent than Tal1/SCL. Cotransfection with both expression vectors for Tal1/SCL and SATB1 with EEGS-SV resulted in the greatest reduction in EEGS-SV reporter gene activity. These results suggest that EEGS can act in an inhibitory role on transcription activity in a Tal1/SCL (and to a lesser extent SATB1) dependent manner that requires the E-box and GATA motifs for optimal activity.
Tal1/SCL increases H3-MeK9 at EEGS
Methylation of histone H3 at lysine 9 (H3-MeK9) is a hallmark of repressive chromatin and provides a high-affinity ligand for binding of the HP1 family of heterochromatin proteins (1). To further explore the mechanism of transcriptional Tal1/SCL repression, ChIP analysis and quantitative TaqMan real-time PCR analysis were employed to determine enrichment or depletion of H3-MeK9 in EEGS chromatin. Anti-dimethyhistone 3 lysine 9 antibody (Upstate, New York) was used for immunoprecipitation of specific chromatin complexes containing histone 3 methylated at lysine 9 ( Figure 4A ). We found that in K562 cells, association of EEGS with methylated H3 at lysine 9 increased three-fold with Tal1/SCL over expression. This change correlated with an increase in HP1 binding to EEGS, ChIP was repeated using anti-HP1 antibody (Upstate, NY) ( Figure 4B ). Quantitative real-time PCR revealed a 24-fold increase in HP1 association with EEGS chromatin when Tal1/SCL expression was enforced. In Tal1/SCL over expressed cells, the large difference in HP1 binding to EEGS compared with H3 methylation of EEGS associated chromatin may reflect in part additional contributions from mono-or trimethylated-histone 3 lysine 9 or differences in the efficiency of the respective antibodies in the ChIP assay. Nevertheless, these data indicate that Tal1/SCL repression is associated with modification of EEGS chromatin, including increase in H3-MeK9 and corresponding increase in HP1 recruitment, and ultimately formation of an inactive transcriptional state in this region.
The methyltransferase Suv39H1 can direct histone H3-MeK9 and heterochromatin dependent gene silencing (41) . We therefore used coimmunoprecipitation analysis to determine if Tal1/SCL could interact with Suv39H1 to facilitate specific histone methylation. Nuclear extract from K562 cells was immunoprecipitated with anti-Tal1/SCL antibody (Santa Cruz, California). Western blotting using anti-Suv39H1 antibody (Upstate, NY) was employed to analyze the protein composition of the precipitated protein complexes. A specific band for Suv39H1 was identified in the Tal1/SCL immune precipitates but not in the pre-immune serum control ( Figure 4C) . Similarly, Tal1/SCL was coimmunoprecipitated with Suv39H1 using anti-Suv39H1 antibody. These results provide evidence for a complex between Tal1/SCL and Suv39H1. Such a complex raises the possibility that Tal1/SCL may act as a transcriptional repressor by promoting the recruitment of this methyltransferase to specific genomic regions. Tal1/SCL promotes a transcriptionally repressed state mediated through EEGS -Endogenous EEGS sequences were enriched in specific markers of inactive chromatin, including MeK9 and HP1 binding, with increased Tal1/SCL expression. In reporter gene assays, we found that EEGS promoted transcriptional repression in the presence of endogenous or elevated Tal1/SCL. To confirm that Tal1/SCL mediated repression by EEGS occurs within the context of appropriate chromatin remodeling, we used the Epstein-Barr virus episomal reporter gene system to mimic the chromatin environment in cells and evaluated EEGS activity. The EEGS-SV40 promoter fragment was cloned into the pREP4/luc to create pREP4/EEGS-Luc, which was transfected into K562 cells and into HeLa cells ( Figure 5 ). We found that in K562 cells EEGS significantly decreased promoter activation and decreased luciferase activity compared with promoter alone ( Figure 5A ). Promoter activity was further decreased by cotransfection with a Tal1/SCL expression vector. In HeLa cells, EEGS had no effect on promoter activity in the absence of Tal1/SCL. With cotransfection of Tal1/SCL, luciferase activity was significantly decreased. Mutation of EEGS had no effect on promoter activity even with cotransfection of Tal1/SCL, which provides evidence for the Tal1/SCL dependent repression of transcription activity by EEGS. SATB1 interacts with Tal1/SCL -The binding of SATB1 to EEGS and the ability of SATB1 to modulate chromatin remodeling raised the possibility that SATB1 could be involved in the Tal1/SCL-mediated repression by EEGS. We cotransfected pREP4/EEGS-Luc with expression vectors for Tal1/SCl and SATB1 into HeLa cells. Quantification of luciferase activity revealed that SATB1 enhanced repression of EEGS by Tal1 ( Figure  5B ). We then used coimmunoprecipitation in K562 cells to determine if there were a direct association between Tal1/SCL and SATB1 ( Figure 5C ). We also carried out similar immunoprecipitation studies in Jurkat cells that express high levels of Tal1/SCL and SATB1 endogenously.
SATB1-containing protein complexes were isolated from nuclear extract by immunoprecipitation using anti-SATB1 serum and analyzed by Western blotting using anti-Tal1/SCL antibody. In both K562 and Jurkat cells, a protein of the proper molecular weight recognized by the Tal1/SCL antibody was observed in the anti-SATB1 immune complexes ( Figure 5C , lanes 2 and 8), but not when preimmune serum was used ( Figure 5C, lanes 1 and 7) . In the converse experiment, anti-Tal1/SCL antibody was used to immunoprecipitate protein complexes from nuclear extract and analyzed by Western blotting using anti-SATB1 serum. Again, for both K562 and Jurkat nuclear extracts, a SATB1 band was detected in the Tal1/SCL complexes ( Figure 5C , lanes 5 and 11). In contrast, no interaction was observed between Tal1/SCL and the SWI/SNF complex in analogous experiments using antibodies specific for SWI/SNF proteins (data not shown). The protein bands from Jurkat cells were more intense, reflecting the higher level of Tal1/SCL and SATB1 expressed in these cells. These data suggest that Tal1/SCL and SATB1 may be associated in a common, multi-protein complex during erythroid differentiation. Tal1/SCL mediated repression by EEGS includes formation of repressive chromatin -To explore whether there was alteration of chromatin structure in the EEGS containing construct, anti-dimethyhistone 3 lysine 9 antibody was used for immunoprecipitation (IP) of specific chromatin complexes containing histone 3 methylated at lysine 9 ( Figure 6A ). We found that in K562 cells, increased Tal1/SCL expression enriched histone H3 methylation at lysine 9 (H3-MeK9) associated with EEGS chromatin. In contrast, only low levels of H3-MeK9 were detected when the EEGS site was mutated (pREP4/ΔEEGS-Luc or ΔEEGS), even with Tal1/SCL over expression. Although there are no Tal1/SCL binding sites in the SV40 promoter, we observed a similar association of H3-MeK9 in the SV40 promoter linked to EEGS. To determine if the increase in EEGS chromatin H3-MeK9 by Tal1/SCL also correlated with an increase in HP1 binding to EEGS in pREP4/EEGS-Luc, ChIP was repeated using anti-HP1 antibody (Upstate, NY) ( Figure 6B ). Quantitative real-time PCR showed an increase of HP1 association with EEGS chromatin when Tal1/SCL expression was enforced. Again, over expressed Tal1/SCL elicited only low levels of HP1 recruitment in the mutant ΔEEGS construct. For the EEGS-linked SV40 promoter, Increased Tal1/SCL also increased HP1 associated with the SV40 promoter linked to EEGS, but not the SV40 promoter linked with the mutant ΔEEGS.
Tal1/SCL recruits mSin3A and histone deacetylase to function as a transcriptional repressor. Histone deacetylation is known to precede histone 3 lysine 9 methylation (3,42). Thus, hypermethylation of histone 3 lysine 9 in chromatin associated with EEGS may be a consequence of histone deacetylation during the formation of inactive transcriptional chromatin. To test these possibilities, we treated K562 cells with the HDAC inhibitor trichostatin A (TSA) and cotransfected the cells with pREP4/EEGS-Luc and the expression vector for Tal1/SCL (Figure 7) . We observed that repression of luciferase activity by increased Tal1/SCL was relieved in a dose dependent manner by addition of TSA ( Figure  7A ). ChIP analysis showed that TSA increased acetylation of histone H3 and H4 associated with pREP4/EEGS-Luc ( Figure 7B ). Concomitantly, TSA decreased H3-MeK9, and HP1 associated with pREP4/EEGS-Luc. These data suggest that Tal1/SCL mediated repression of transcription activity via EEGS requires histone deacetylation.
Tal1/SCL inhibits tropomodulin 4 expression -
Since EEGS mapping to the pericentromere of chromosome 1 (1q11, 1q12) has characteristics of human satellite repeats, EEGS transcription regulation is expected to be species specific. Localization of tropomodulin 4 to 1q12 prompted us to examine tropomodulin 4 expression in K562 cells. Tropomodulin is an actin-capping protein with several isoforms that exhibit varying tissue specificity. Originally identified in erythrocytes, tropomodulin isoforms can be ubiquitous (tropomodulin 3) or tissue specific, with tropomodulin 4 found only in muscle and lens (43, 44) . Tropomodulin 4 expression was observed in adult chicken erythrocytes but not in human erythroid cells (45, 46) . Surprisingly, we found that K562 cells exhibited a low level of tropomodulin 4 transcripts ( Figure 8A ). Quantitative RT-PCR with primers and probes specific for human tropomodulin 4 indicated that the level of tropomodulin 4 in K562 cells was 0.15 times the level in human skeletal muscle mRNA ( Figure  8B ). We identified two E-boxes upstream of the tropomodulin 4 coding region (340 bp 5' and 646 bp 5'), but no Tal1/SCL binding was observed by ChIP analysis (data not shown). With over expression of Tal1/SCL in K562 cells, the level of tropomodulin 4 decreases to 30 fold less than that in skeletal muscle. This decrease in tropomodulin 4 expression was accompanied by a 7-fold increase in H3-MeK9 in tropomodulin 4 associated chromatin ( Figure 8C ). While HP1 does not appear to bind to tropomodulin 4 in K562 cells, HP1 binding to tropomodulin 4 chromatin was readily detected in Tal1/SCL over expressing K562 cells ( Figure 8D ). The marked increase in H3-MeK9 and HP1 associated with tropomodulin 4 chromatin in Tal1/SCL over expressing K562 cells suggests a shift toward a transcriptionally inactive state and is consistent with decreased tropomodulin 4 expression. Note, however, that tropomodulin 4 maps to the telomeric end of 1q12 and the possibility remains that regulation by Tal1/SCL may be via other regulatory mechanisms.
DISCUSSION
Over expression of Tal1/SCL in human hematopoietic CD34+ cells increased the longterm culture initiating cell (LTC-IC) potential, an activity that required Tal1/SCL DNA binding (24) . We hypothesize that Tal1/SCL binding to EEGS DNA found in pericentric satellite DNA may not be related to specific gene expression during erythroid differentiation as observed for glycophorin A. Rather, Tal1/SCL binding to EEGS may be related to chromatin organization such as pericentric heterochromatin and may provide clues to its function in maintaining LTC-IC potential in early human hematopoietic progenitor cells.
We demonstrate for the first time that Tal1/SCL, a lineage specific transcription factor, binds in vivo to pericentric DNA and increases H3-MeK9 and HP1 association with EEGS chromatin and transcription repression. This illustrates a new mechanism for Tal1/SCL as a repressor of transcription beyond its association with the co-repressor mSin3A (13) . Enzymes that alter N-terminal histone tails and proteins that bind to specific modifications provide sequential changes in histones and chromatin structure that give rise to a "histone code" for epigenetic regulation (1) . Actively transcribed genes are generally associated with euchromatin, while silent genes tend to be associated with heterochromatin. Heterochromatin is characterized by hypoacetylation and hypermethylation at lysine 9 of histone 3 (H3-K9) and enriched in HP1 (47, 48) . HP1 is sufficient to generate silent chromatin in regions of the genome with transcriptional potential, is relatively independent of DNA sequences and depends on the extent of H3-MeK9. Pericentric DNA contains high-copy tandem repeats (satellite DNAs) linked to formation of heterochromatin (49) . Some repressors operate at short distances usually binding to the promoter region and recruiting histone deacetylases to remove acetyl groups from lysine residues of histone tails (50, 51) . In contrast, the spread of long-range repression is believed to involve propagation of histone hypoacetylation and generation of H3-MeK9 along the chromatin fiber throughout a region (3, 42) . Localization of EEGS to pericentric DNA suggests that Tal1/SCL repression via EEGS may have regional rather than gene-specific effects.
The effects of Tal1/SCL on chromatin remodeling of EEGS DNA are functionally linked to a shift towards a transcriptionally repressive state. The pREP4 reporter gene construct displays most of the hallmarks of normal chromatin structure; it contains the EBV origin of replication and a transcription unit for EBNA-1 that ensures episomal replication of the plasmid in mammalian cells (52) . The increase of H3-MeK9 and HP1 in chromatin associated with EEGS and the linked promoter suggests that Tal1/SCL can act as repressor through heterochromatin formation. Methylation of H3K9 by Suv39H1 provides a docking site for dynamic HP1 binding. Suv39h histone methyltransferase activity is required for mammalian pericentric heterochromatin formation and for genomic stability during development (53) . The absence of Suv39h, lack of Suv39h results in low level H3-K9 methylation at pericentric DNA (11) . In addition, major satellite repeats localized at pericentric heterochromatin exhibit an increase in transcriptional activity in murine ES cells lacking Suv39h. Further study is necessary to determine if interaction between Tal1/SCL and Suv39H1, as predicted by the coimmunoprecipitation results, is responsible for hypermethylation and HP1 binding to chromatin in pericentric EEGS DNA and flanking regions. The histone deacetylase inhibitor, TSA, increased EEGS histone acetylation, decreased EEGS associated H3-MeK9 and HP1, and blocked Tal1/SCL-mediated repression by EEGS in a dose dependent manner. This is supportive of the notion that deacetylation precedes methylation of histone tails, and is consistent with previously described Tal1/SCL repressor activity via interaction with the co-repressor mSin3A.
In addition EEGS DNA binding to Tal1/SCL, EEGS binds to SATB1 in vivo. In Tcells SATB1 acts as landing platform for chromatin modifiers and can recruit mSin3A, HDAC and other subunits of the NURD chromatin remodeling complex to mediate deacetylation of histones (6, 7) . The identification of a protein complex containing Tal1/SCL and SATB1 along with the enhancement of Tal1/SCL-mediated repression by increasing SATB1 loading suggests that Tal1/SCL mediated repression via EEGS may result from interaction with several proteins that affect chromatin remodeling. Interaction of Tal1/SCL and SATB1 with mSin3A may be particularly relevant since its associated protein, mSds3, an essential component of the mSin3/HDAC corepressor complex, appears to be required for pericentric heterochromatin formation and chromosome segregation in mammalian cells (12) . Indeed, repression by a Tal1/SCL binding motif overlapping with a SATB1 binding site may not be unique to EEGS. We identified a second Tal1/SCL binding DNA fragment, E5S, that contains 5 E-boxes and a region that is 97% homologous to both a SATB1 binding motif and to DNA that binds to vimentin, an intermediate filament protein that behaves like a nuclear matrix protein (54) . E5S also decreases transcription activity in reporter gene assays (data not shown). If Tal1/SCL binding to pericentric EEGS DNA plays a role in maintaining LTC-IC potential in early human hematopoietic progenitor cells or in erythroid differentiation, an analogous interaction might be expected in the mouse. For example, a MAR from the murine insulin-like growth factor 2 gene (gi:2405571) that contains a SATB1 binding motif co-localizes with several candidate E-boxes and GATA motifs. Several mouse major γ-satellite repeats localizing to pericentric heterochromatin also contain the consensus E-box CANNTG motifs (55). While SATB1 contributes to Tal1/SCL repression via EEGS, it is not required as demonstrated by EEGS-mediated repression in HeLa cells. Satellite repeats from pericentric heterochromatin are not transcriptionally inert and it is possible to generate transcripts from major satellite repeats (11) . Furthermore, several EEGScontaining clones corresponding to RNA transcripts are found in a subtracted library specific for differentiating primary erythroid progenitor cells (40) . While we were not able to identify any genes encoded in proximity of EEGS sequences, Tal1/SCL affected repression in erythroid cells of the tropomodulin 4 gene that also localized to chromosome 1q12. Tal1/SCL over expression increased associated H3-MeK9 and HP1, consistent with a shift toward a less transcriptionally active state. Repression of tropomodulin 4 in erythroid cells mediated by Tal1/SCL may relate to spreading of a heterochromatin state from the pericentromere, although tropomodulin 4 is located distal to the centromere at 1q12.
In the nucleus, repetitive DNA can localize to form regions of chromatin in a repressed state, which can "spread" stochastically to nearby genes (56) . Repression can also act "in trans" and subnuclear localization of differentially express genes to these heterochromatin compartments relates to transcription repression. For example, the β-globin gene cluster is segregated from α-satellite-rich heterochromatin in differentiating erythroid cells, but is associated with pericentric heterochromatin in lymphocytes in which the globin genes are silenced (57, 58) . Activation of differentiation stage-specific enhancers such as the HS2 (hypersensitive site 2) core in the 5' locus control region (LCR) of the β-globin cluster can prevent a gene from residing in proximity to heterochromatin to maintain an active state via hyperacetylation of histones (57) . Alternatively, DNA binding of select transcription factors such as Ikaros during B lymphocyte differentiation can mediate gene silencing and sequester genes close to pericentromeric regions (59, 60) . The spatial arrangements of centromeric heterochromatin are different between fibroblasts and hematopoietic cells with distinct myeloid and lymphoid patterns, raising the possibility of tissue-specific heterochromatin organization (61) . It has been speculated that different satellite repeats may form distinct heterochromatin compartments and participate in cell-type stage-specific gene regulation by providing binding sites for specific transcription factors (56) . Furthermore, the "histone code" is read in the context of other interactions (62) .
We provide evidence for Tal1/SCL binding in vivo to pericentric EEGS DNA to promote a transcriptionally repressive state. This activity exemplifies epigenetic regulation through histone modification and the "histone code." Potential interactions of Tal1/SCL with mSin3A and possibly Suv39H1 have implications for Tal1/SCL binding to EEGS in pericentric heterochromatin formation in hematopoietic/erythroid cells (11, 12) . The actions of Tal1/SCL in regulating LTC-IC potential in early human hematopoietic progenitor cells may involve modulation of higher order chromatin organization above and beyond its ability to affect chromatin acetylation or methylation at the sites of specific genes. The extent to which Tal1/SCL mediated transcription repression of pericentric chromatin contributes to the maintenance of hematopoietic cells in a less differentiated pluripotent or multipotent state warrants further investigation. FIGURE LEGENDS Figure 1 . Isolation of genomic Tal1/SCL binding sites. A) Enrichment for DNA fragments binding to Tal1/SCL was assayed by EMSA. All lanes contain radio-labeled Tal1/SCL preferred DNA binding sequence (T1) as probe and K562 nuclear extract. Competitors used to compete for Tal1/SCL binding were no competitor (NC) (lanes 1 and 12) , PCR amplification of DNA from the first cycle of immunoselection of SCL/Tal1-DNA complexes at 50 ng, 500 ng and 5000 ng (lanes 2, 3 and 4, respectively), from the second cycle of selection (lanes 5, 6 and 7, respectively), from the third cycle of selection (lanes 8, 9 and 10, respectively), and EEGS DNA (E) (lane 13) that competes for Tal1/SCL binding comparable to T1 (lane 14) . No nuclear extract (ne) was used in lane 11. B) Radio-labeled Tal1/SCLprobe is competed by increasing amounts of EEGS at 50, 100, 150, 200ng (lanes 2 to 5). C) EEGS DNA sequence shows homology to human satellite DNA. HST3 indicates HSSAT3 (GI: 36345), HSII indicates HUMSATIIX (GI: 1220362), HIII indicates HSSATIIIA (GI: 36364), and SATB1 indicates satellite 2 sequence identified as a SATB1 binding site (63) . Two E-boxes (bold underline) and GATA binding motif (wavy underline) are indicated. D) EEGS chromosome localization is determined using metaphase chromosomes for FISH and BAC (CITBI-E1) isolated from a human genomic BAC library and contains the full length EEGS sequence (Rhodamine signal). I) Hybridization to the pericentromeric region of chromosome 1q12 is shown. II) Rhodamine image of the same metaphase is shown separately. III) DAPIinverted image is used for chromosomal identification. IV) DAPI image is used to visualize individual chromosomes. . Tal1/SCL increases EEGS histone methylation and flanking DNA sequence. A) In vivo ChIP was carried out using antibody specific for histone H3 methylated at lysine 9 (H3-MeK9) in K562 cells transfected with the pREP4/EEGS-Luc construct to examine chromatin associated with EEGS and the flanking SV40 promoter fragment. PCR primers and probe specific for the EEGS core and SV40 promoter were used for real-time PCR quantification of the corresponding amount of DNA associated with HF3-MeK9 with and without over expression of Tall/SCL. B) ChIP was repeated using antibody specific for heterochromatin protein HP1 and DNA corresponding to chromatin associated with HP1 from EEGS and flanking SV40 promoter was quantified by real-time PCR. 
